Gwo Xi Stem Cell Applied Technology Co., Ltd. (6704) Stock Statistics & Valuation Metrics
Total Valuation
Gwo Xi Stem Cell Applied Technology Co., Ltd. has a market cap or net worth of TWD 2.12B. The enterprise value is ―.
- Market Cap
- TWD 2.12B
- Enterprise Value
- ―
Share Statistics
Gwo Xi Stem Cell Applied Technology Co., Ltd. has 105,949,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 105,949,320
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Gwo Xi Stem Cell Applied Technology Co., Ltd.’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -7.79%.
- Return on Equity (ROE)
- -0.14
- Return on Assets (ROA)
- -0.08
- Return on Invested Capital (ROIC)
- -7.79%
- Return on Capital Employed (ROCE)
- -0.09
- Revenue Per Employee
- 3.40M
- Profits Per Employee
- -1.46M
- Employee Count
- 55
- Asset Turnover
- 0.19
- Inventory Turnover
- 10.24
Valuation Ratios
The current PE Ratio of Gwo Xi Stem Cell Applied Technology Co., Ltd. is -18.79. Gwo Xi Stem Cell Applied Technology Co., Ltd.’s PEG ratio is 0.54.
- PE Ratio
- -18.79
- PS Ratio
- 12.99
- PB Ratio
- 2.49
- Price to FCF
- -30.61
- Price to Operating Cash Flow
- -43.37
- PEG Ratio
- 0.54
Income Statement
In the last 12 months, Gwo Xi Stem Cell Applied Technology Co., Ltd. had revenue of 187.02M and earned -80.52M in profits. Earnings per share was -0.84.
- Revenue
- 187.02M
- Gross Profit
- 73.50M
- Operating Income
- -73.67M
- Pretax Income
- -80.52M
- Net Income
- -80.52M
- EBITDA
- -15.20M
- Earnings Per Share (EPS)
- -0.84
Cash Flow
In the last 12 months, operating cash flow was -42.81M and capital expenditures -24.16M, giving a free cash flow of -66.97M billion.
- Operating Cash Flow
- -42.81M
- Free Cash Flow
- -66.97M
- Free Cash Flow per Share
- -0.70
Dividends & Yields
Gwo Xi Stem Cell Applied Technology Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.14%
- Earnings Yield
- -5.12%
Stock Price Statistics
- Beta
- 0.10
- 52-Week Price Change
- -25.23%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 32.27
- Average Volume (3m)
- 121.75K
Financial Position
Gwo Xi Stem Cell Applied Technology Co., Ltd. as a current ratio of 1.98, with Debt / Equity ratio of 62.93%
- Current Ratio
- 1.98
- Quick Ratio
- 1.88
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- -11.37
- Interest Coverage Ratio
- -7.49
Taxes
In the past 12 months, Gwo Xi Stem Cell Applied Technology Co., Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Gwo Xi Stem Cell Applied Technology Co., Ltd. EV to EBITDA ratio is -68.32, with an EV/FCF ratio of -31.90.
- EV to Sales
- 13.53
- EV to EBITDA
- -68.32
- EV to Free Cash Flow
- -31.90
- EV to Operating Cash Flow
- -49.90
Balance Sheet
Gwo Xi Stem Cell Applied Technology Co., Ltd. has TWD 361.74M in cash and marketable securities with TWD 353.19M in debt, giving a net cash position of TWD 8.55M billion.
- Cash & Marketable Securities
- TWD 361.74M
- Total Debt
- TWD 353.19M
- Net Cash
- TWD 8.55M
- Net Cash Per Share
- TWD 0.08
- Tangible Book Value Per Share
- TWD 6.12
Margins
Gross margin is 32.69%, with operating margin of -58.37%, and net profit margin of -62.74%.
- Gross Margin
- 32.69%
- Operating Margin
- -58.37%
- Pretax Margin
- -62.73%
- Net Profit Margin
- -62.74%
- EBITDA Margin
- -19.81%
- EBIT Margin
- -58.37%
Analyst Forecast
The average price target for Gwo Xi Stem Cell Applied Technology Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -14.63%
- EPS Growth Forecast
- -41.20%
